Find information on Immunity Status Testing Antibody including antibody testing, serology testing, immune response testing, and immunoglobulin levels. Learn about relevant healthcare codes for immunity testing, clinical documentation requirements for antibody tests, and medical coding guidelines for serological tests. This resource provides details on understanding immunity status, interpreting antibody test results, and the role of healthcare professionals in immunity assessment.
Also known as
Encounter for immunization
Encounters for prophylactic vaccination and immunity testing.
Encounters for examinations
Includes general medical examinations and other screening.
Encounter for screening for infectious/parasitic diseases
Covers screening for various infectious diseases.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the antibody test for COVID-19?
When to use each related code
| Description |
|---|
| Antibody Testing Immunity Status |
| T-Cell Immunity Testing |
| Antigen Testing (acute infection) |
Coding lacks specificity. Documentation must identify the target antibody for accurate code assignment (e.g., COVID-19, MMR).
Separate coding for antibody testing and interpretation when a single code exists. Ensure proper code selection for combined services.
Lack of documented medical necessity for immunity status testing. Clear clinical indication required to support billing and prevent denials.
Patient presents for immunity status testing antibody assessment. The reason for testing includes evaluation of immune response to vaccination or prior infection. Patient reports (mention specific symptoms or lack thereof related to suspected infection or post-vaccination status, e.g., no history of measles, recent tetanus vaccination, concerns about prior COVID-19 infection). Relevant medical history includes (list pertinent medical conditions, immunizations, prior infections, relevant medications such as immunosuppressants, etc.). Physical examination reveals (document relevant findings or note "unremarkable" if applicable). Differential diagnosis includes prior exposure to the suspected pathogen, successful vaccination, or lack of adequate immune response. Laboratory testing ordered includes (specify antibody titer tests such as IgG, IgM, or other relevant immune assays, e.g., anti-HBs, varicella zoster antibody, anti-SARS-CoV-2 antibody). Plan includes discussion of test results upon receipt, counseling regarding vaccination recommendations based on antibody titers, and potential further investigation if results are inconclusive. Medical coding considerations include appropriate ICD-10-CM diagnosis codes for the suspected infection or reason for testing (e.g., Z23 Encounter for immunization, Z01.818 Encounter for antibody response status, B94.8 Sequelae of viral infection) and CPT codes for the specific antibody tests performed (e.g., 86701, 86703, 86619). Patient education provided regarding the significance of antibody testing, the interpretation of results, and the implications for future immunity and potential need for vaccination or other preventive measures. Follow-up scheduled as needed to review results and discuss further management.